Newsweek: Molly, Psychedelic Drug, Shows Great Promise As Mental Health Treatment, New Study Finds

Summary: “What the MDMA clearly did, is it allowed people to go into dark places where ordinarily they did not want to go,” says Bessel van der Kolk, M.D., a Principal Investigator of MAPS’ Phase 3 trial of MDMA-assisted therapy for PTSD, in Newsweek. “Sometimes they were quite upset during the sessions. But they always came up with unexpected attitude changes, insights, insights that were more than just intellectual, that often gave them an entirely different orientation towards themselves. Self-forgiveness became a very important part of it also, replacing self-blame for what happened.”

Originally appearing here.